Cytodyn Inc (CYDY)

[PNW_Ironman]

Thanks for all of your posts and numbers lately!

Side note to your update on Ibalizumab (IZ):

Even if Thai-Med is granted the approval to move from IV (intravenous) to IM (intramuscular), a healthcare professional will still need to administer this, as IM is not considered to be a “self-administration” route.
Pro-140 will still have a major advantage with SC or (SQ) (subcutaneous) route self-administration.
This becomes a significant financial savings and care-plan/logistical advantage with regards to implementation of treatment. (As well as patient compliance in my opinion, much less painful and easily self-administered).